Oxalate descarboxylase receives FDA orphan drug designation for pediatric hyperoxaluria March 3, 2016
Thrasos announces successful outcome to phase II trial of THR-184 to prevent acute kidney injury March 1, 2016
A new patent listed and additional orphan drug designation granted for Procysbi in the U.S. Jan. 27, 2016
RSS